Actylis Executive and Leadership Team

Scott Thomson, the Chief Executive Officer at Actylis, directs the overarching corporate strategy and operational execution. Thomson guides the company's expansion within the Life Sciences, Specialty Chemicals, and Agriscience sectors, ensuring alignment with market demands for critical raw materials and performance ingredients. This leadership role involves optimizing the hybrid manufacturing and global sourcing model to deliver maximum flexibility and reliability for customer requirements. Thomson's focus remains on driving growth through strategic partnerships and enhancing the company's global footprint. The Chief Executive Officer ensures that Actylis maintains industry-leading standards in quality documentation and regulatory compliance across all operations. Scott Thomson's vision propels the company's commitment to providing unique ingredient solutions.

Douglas Roth, the Chief Financial Officer at Actylis, oversees all financial operations and strategic financial planning. Roth manages the company's fiscal health, ensuring robust financial controls and driving profitability across its diverse business units. This executive directs capital allocation, investment strategies, and financial risk management to support Actylis's global growth initiatives in the Life Sciences, Specialty Chemicals, and Agriscience industries. The Chief Financial Officer plays a crucial part in evaluating potential acquisitions and optimizing the financial performance of the company's expanding portfolio of GMP and non-GMP facilities. Douglas Roth's financial acumen is essential for maintaining the company's competitive edge and supporting its hybrid manufacturing and global sourcing model.

Trae Etre, the Senior Vice President & Chief Financial Officer at Actylis, manages critical financial functions and supports strategic initiatives across the organization. Etre collaborates closely with the Chief Financial Officer to ensure financial integrity and drive operational efficiency. This role involves detailed financial analysis, budgeting, and forecasting to support Actylis's operations in manufacturing and sourcing critical raw materials and performance ingredients. Trae Etre contributes to the financial oversight of the company's global facilities and sourcing network, ensuring compliance and fiscal responsibility. The Senior Vice President & Chief Financial Officer's efforts are vital for sustaining the company's growth trajectory and supporting its diverse customer base in the Life Sciences, Specialty Chemicals, and Agriscience sectors.

Arpit Butala, the Director and Chief Financial Officer APAC at Actylis, directs financial strategy and operations within the Asia-Pacific region. Butala ensures financial compliance and drives fiscal performance across Actylis's APAC manufacturing and sourcing activities, supporting the Life Sciences, Specialty Chemicals, and Agriscience industries. This leadership position involves managing regional budgets, optimizing financial resources, and providing critical financial insights to support business development in the APAC market. The Director and Chief Financial Officer APAC plays a key role in the financial integration of regional operations with the company's global strategy. Arpit Butala's financial oversight is instrumental in strengthening Actylis's presence and reliability in the Asia-Pacific region.

Keith Wilkinson, the President, North America at Actylis, leads the company's strategic direction and operational execution across the North American market. Wilkinson oversees the sales, distribution, and customer support functions, ensuring Actylis delivers critical raw materials and performance ingredients to its clients in the Life Sciences, Specialty Chemicals, and Agriscience sectors. This executive drives market penetration and revenue growth by leveraging the company's hybrid manufacturing and global sourcing capabilities. The President, North America ensures adherence to industry-leading standards of quality documentation and regulatory compliance throughout the region. Keith Wilkinson's leadership is pivotal in expanding Actylis's footprint and solidifying its reputation for reliability and flexibility in North America.

Damien O'Rourke, the President Global Life Sciences at Actylis, spearheads the strategic growth and operational management of the Life Sciences division worldwide. O'Rourke directs the development and supply of critical raw materials and performance ingredients tailored for pharmaceutical, biotechnology, and medical device applications. This leadership role involves fostering innovation, ensuring stringent GMP compliance, and expanding Actylis's global reach within this highly regulated sector. The President Global Life Sciences collaborates with R&D and manufacturing teams to optimize the product portfolio and enhance customer solutions. Damien O'Rourke's expertise is crucial for maintaining Actylis's position as a trusted partner in the global Life Sciences industry, driving value through specialized ingredients and reliable sourcing.

Mark Bostel, the President, Global Nutrition and OTC at Actylis, directs the strategic vision and operational execution for the company's global nutrition and over-the-counter (OTC) product lines. Bostel oversees the development, manufacturing, and distribution of specialized ingredients and performance materials essential for dietary supplements, functional foods, and OTC pharmaceutical products. This executive drives market expansion and strengthens Actylis's presence in these key consumer health sectors by leveraging the company's robust sourcing network and manufacturing capabilities. The President, Global Nutrition and OTC ensures that all products meet rigorous quality and regulatory standards demanded by these markets. Mark Bostel's leadership is instrumental in delivering innovative and reliable ingredient solutions to a global customer base.